Edge Science LONDON, UK / ACCESS Newswire / May 15, 2025 / Longevity Method, a pioneering health and wellness company, proudly announces its launch, unveiling a range of anti-aging solutions designed ...

Leading life sciences technology company to accelerate adoption of automated procurement and supplier diversity worldwideBOSTON and LONDON , May 15, 2025 (GLOBE NEWSWIRE) -- Tariffs, trade barriers, ...

CNX Therapeutics to accelerate European growth strategy with Inflexion's £2.3bn Continuation FundLondon, May 15th, 2025 – CNX Therapeutics Limited (“CNX Therapeutics”), a European specialty ...

Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025HDP-101 demonstrated complete response in one female patient from cohort 5R&D Webinar to be ...

LEO Pharma delivers 9% revenue growth at constant exchange rates and doubles adjusted EBITDA margin to 16% Ballerup, Denmark, 15 May, 2025 - In Q1, LEO Pharma continued its robust growth, driven by ...

Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record ...

Simris Group's Q1 2025 report released today, highlights a period of significant focus on advancing their ADC payload ...

PersonnelLonza Appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer 15.05.2025 / 09:00 CET/CEST Andreas Bohrer has served as Lonza’s Group General Counsel and Company Secretary since ...

GENEVA, SWITZERLAND / ACCESS Newswire / May 15, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief), a biopharmaceutical company committed to delivering innovative ...

Development of Sales/RatingCantourage achieves another record revenue: EUR 11.1 million in April 2025 15.05.2025 / 07:07 CET/CESTThe issuer is solely responsible for the content of this ...

The global bedless hospitals market is set to experience robust growth, with a projected value of USD 1,829.51 million by 2033, according to Future Market Insights. This growth represents a compound ...

The global antisense oligonucleotides market is poised for remarkable growth over the next decade, projected to rise from USD 2,913.5 million in 2023 to USD 5,519.6 million by 2033 moving forward with ...